United States In Vivo Toxicology Market Size, Trends, Growth drivers, Industry insights | Top Companies - MATTEK CORPORATION, Vimta Labs Ltd, Merck KGaA | Exclusive report by DataM intelligence

Leander, Texas and Tokyo, Japan - Jan.16.2026
As per DataM intelligence research report "In Vivo Toxicology Market is anticipated to grow at a high CAGR during the forecast period 2024-2031."

The in vivo toxicology market is expanding as pharmaceutical and biotech industries demand more precise preclinical testing. Advanced imaging, AI-based data analysis, and high-throughput screening enhance safety and predictive accuracy. Rising drug development activities and regulatory requirements are fueling market growth.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/in-vivo-toxicology-market?prasad

In Vivo Toxicology Market: Competitive Intelligence
MATTEK CORPORATION, Vimta Labs Ltd, Merck KGaA, NUVISAN GmbH, Charles River Laboratories, Eurofins Scientific, Nagi Bioscience, Labcorp Drug Development

In the In Vivo Toxicology Market, MATTEK CORPORATION, Vimta Labs Ltd, Merck KGaA, NUVISAN GmbH, Charles River Laboratories, Eurofins Scientific, Nagi Bioscience, and Labcorp Drug Development collectively bolster a critical segment of preclinical safety science that underpins drug development, chemical risk assessment, and regulatory decision-making. These organizations provide in vivo study design, execution, and interpretation services that help sponsors evaluate systemic toxicity, organ-specific effects, carcinogenicity, reproductive safety, and dose-response relationships-core data required by global regulatory authorities. Their integrated capabilities support discovery through IND/CTA enabling studies, reducing time-to-clinic while helping ensure compliance with evolving safety standards. By offering global reach and standardized quality systems, they help biopharmaceutical and chemical developers manage complex study logistics and data integrity across diverse species and experimental models. Together, they reinforce the In Vivo Toxicology Market as a dependable foundation for translational safety evaluation and risk mitigation across emerging and established pipelines.

Individually and in synergy, these companies' strengths enhance competitive differentiation and market depth within the In Vivo Toxicology Market by blending specialized technologies, regulatory expertise, and scale. MATTEK CORPORATION contributes advanced tissue models and integrated platforms that complement in vivo assessments with translational context. Vimta Labs Ltd and NUVISAN GmbH provide localized study execution and regulatory alignment across key markets, supporting sponsors with region-specific compliance frameworks. Merck KGaA and Eurofins Scientific bring broad toxicology service portfolios and analytical depth that enrich study endpoints and data interpretation. Charles River Laboratories and Labcorp Drug Development offer large-scale, end-to-end preclinical programs with robust quality assurance and cross-disciplinary expertise that help streamline safety evaluation across multi-modality pipelines. Nagi Bioscience adds value with focused biological insights and targeted assessments that deepen mechanistic understanding. Together, these organizations create a resilient, scientifically rigorous In Vivo Toxicology Market that empowers developers to make informed, risk-aware decisions throughout the lifecycle of therapeutic and chemical innovation.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/in-vivo-toxicology-market?prasad

United States: Recent Industry Developments

✅ In January 2026, Charles River Laboratories launched automated in vivo toxicology platforms integrating robotic animal handling, AI-enabled monitoring, and high-throughput data analytics to accelerate preclinical safety testing.

✅ In November 2025, Covance (Labcorp) invested $50 million in automated toxicology labs with robotics, AI-based behavior monitoring, and real-time analytics to enhance throughput and data reproducibility.

✅ In August 2025, Envigo deployed robotics-assisted in vivo toxicology workflows with AI integration for automated dosing, observation, and analytics, increasing efficiency and reducing human error.

✅ In June 2025, WuXi AppTec implemented automated preclinical toxicology platforms with AI monitoring, robotic sample handling, and integrated data capture for reproducible safety studies.

Japan: Recent Industry Developments

✅ In January 2026, Shin Nippon Biomedical Laboratories deployed automated AI-assisted in vivo toxicology testing systems, supported by $20 million investment, combining robotics and real-time analytics to improve precision and reproducibility.

✅ In October 2025, Charles River Japan introduced robotic handling platforms with AI-based observation tools for preclinical toxicology studies, enhancing throughput and data consistency.

✅ In July 2025, Japan Bioassay Laboratories implemented automated in vivo toxicology systems integrating AI sensors and robotics to optimize workflow and improve study accuracy.

✅ In April 2025, Kyoto University research teams piloted automated AI-assisted toxicology platforms with robotic animal handling and real-time monitoring to ensure reproducible and efficient experiments.

Segment Covered in the In Vivo Toxicology Market:
By Product Type
The market is segmented into kits (30%), reagents (40%), and equipment (30%), with reagents dominating due to their essential role in a wide variety of in vivo studies and preclinical testing workflows. Kits are gaining traction for standardized, ready-to-use protocols that reduce variability, while equipment adoption is rising with increasing investment in imaging and analytical platforms.

By Test Type
Test types include subchronic toxicity tests (25%), chronic toxicity tests (20%), carcinogenicity tests (15%), and others (40%). Subchronic toxicity tests dominate as they are standard requirements in preclinical safety assessment. Chronic and carcinogenicity tests are growing steadily due to stricter regulatory mandates and rising demand for long-term safety data.

By Technology
Technologies include in vivo imaging (30%), in silico models (20%), omics technologies (25%), and others (25%). In vivo imaging leads due to its ability to provide non-invasive, real-time monitoring of biological processes. Omics technologies are gaining momentum with the rise of personalized medicine, while in silico models are increasingly used to reduce animal testing and improve predictive toxicology.

By End User
End-users include pharmaceutical and biotechnology companies (45%), contract research organizations (CROs) (35%), and academic & research institutions (20%). Pharmaceutical and biotech companies dominate due to their preclinical drug development pipelines. CROs are expanding rapidly as outsourcing of preclinical studies grows, while academic research continues to adopt in vivo toxicology for mechanistic studies and innovation.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=in-vivo-toxicology-market

Regional Analysis
North America - 40% Share
North America leads due to the presence of major pharmaceutical and biotech companies, advanced laboratory infrastructure, and stringent regulatory frameworks driving preclinical testing requirements.

Europe - 25% Share
Europe holds significant share driven by regulatory mandates in the EU, growing CRO presence, and adoption of advanced imaging and omics technologies in preclinical research.

Asia Pacific - 25% Share
Asia Pacific is witnessing rapid growth due to expansion of pharmaceutical manufacturing, increasing CRO activities, and supportive government initiatives in China, India, and Japan.

Latin America - 5% Share
Latin America shows moderate adoption with increasing pharmaceutical R&D activities and CRO operations.

Middle East & Africa - 5% Share
The Middle East & Africa market is nascent, with growth opportunities in academic research and early-stage preclinical services.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.